- Home
- AIRE vs CLRB Comparison
AIRE vs CLRB Comparison
Compare AIRE & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- CLRB
- Stock Information
- Founded
- AIRE 2021
- CLRB 2002
- Country
- AIRE United States
- CLRB United States
- Employees
- AIRE N/A
- CLRB N/A
- Industry
- AIRE
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- CLRB Health Care
- Exchange
- AIRE Nasdaq
- CLRB Nasdaq
- Market Cap
- AIRE 13.7M
- CLRB 14.2M
- IPO Year
- AIRE N/A
- CLRB N/A
- Fundamental
- Price
- AIRE $0.34
- CLRB $4.44
- Analyst Decision
- AIRE Hold
- CLRB Hold
- Analyst Count
- AIRE 1
- CLRB 2
- Target Price
- AIRE N/A
- CLRB N/A
- AVG Volume (30 Days)
- AIRE 59.7M
- CLRB 113.2K
- Earning Date
- AIRE 08-21-2025
- CLRB 08-14-2025
- Dividend Yield
- AIRE N/A
- CLRB N/A
- EPS Growth
- AIRE N/A
- CLRB N/A
- EPS
- AIRE N/A
- CLRB N/A
- Revenue
- AIRE $1,853,629.00
- CLRB N/A
- Revenue This Year
- AIRE $369.52
- CLRB N/A
- Revenue Next Year
- AIRE $68.67
- CLRB N/A
- P/E Ratio
- AIRE N/A
- CLRB N/A
- Revenue Growth
- AIRE 1925.60
- CLRB N/A
- 52 Week Low
- AIRE $0.14
- CLRB $4.36
- 52 Week High
- AIRE $4.49
- CLRB $68.70
- Technical
- Relative Strength Index (RSI)
- AIRE 47.75
- CLRB 35.40
- Support Level
- AIRE $0.33
- CLRB $4.72
- Resistance Level
- AIRE $0.37
- CLRB $5.09
- Average True Range (ATR)
- AIRE 0.05
- CLRB 0.38
- MACD
- AIRE -0.00
- CLRB 0.09
- Stochastic Oscillator
- AIRE 6.12
- CLRB 3.42
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.